O1-1 O1-2 O1-3 O1-4 O1-5 O1-6
|
|
|
- さやな みしま
- 5 years ago
- Views:
Transcription
1
2 O1-1 O1-2 O1-3 O1-4 O1-5 O1-6
3 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12
4 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19
5 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25
6 O1-26 O1-27 O1-28 O1-29
7
8 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35
9 O1-36 O1-37 O1-38 O1-39 O1-40 O1-41 O1-42
10 O1-43 O1-44 O1-45 O1-46
11 O1-47 O1-48 O1-49 O1-50 O1-51 O1-52
12 O1-53 O1-54 O1-55 O1-56 O1-57 O1-58 O1-59
13 O1-60 O1-61 O1-62 O1-63 O1-64 O1-65
14 O1-66 O1-67 O1-68 O1-69 O1-70 O1-71 O1-72
15 O1-73 O1-74 O1-75 O1-76 O1-77 O1-78
16 O1-79 O1-80 β O1-81 O1-82 O1-83 O1-84
17 O1-85 O1-86 O1-87 O1-88 O1-89 O1-90
18 O1-91 O1-92 O1-93 O1-94 O1-95 O1-96 O1-97
19 O1-98 O1-99 O1-100 O1-101 O1-102 O1-103
20
21 O2-1 O2-2 O2-3 O2-4 O2-5 O2-6
22 O2-7 O2-8 O2-9 O2-10 O2-11 O2-12
23 O2-13 O2-14 O2-15 O2-16 O2-17 O2-18 γ O2-19 O2-20
24 O2-21 O2-22 O2-23 O2-24 O2-25 O2-26
25 O2-27 O2-28 O2-29 O2-30 O2-31
26 O2-32
27
28 O2-33 O2-34 O2-35 O2-36 O2-37 O2-38
29 O2-39 O2-40 O2-41 O2-42 O2-43 O2-44 O2-45
30 O2-46 O2-47 O2-48 O2-49 O2-50 O2-51
31 O2-52 O2-53 O2-54 O2-55 O2-56 O2-57
32 O2-58 O2-59 O2-60 O2-61 O2-62 O2-63
33 O2-64 O2-65 O2-66 O2-67 O2-68 O2-69 O2-70
34 O2-71 O2-72 O2-73 O2-74 O2-75 O2-76
第86回日本感染症学会総会学術集会後抄録（I）
κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β
1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915
_0212_68<5A66><4EBA><79D1>_<6821><4E86><FF08><30C8><30F3><30DC><306A><3057><FF09>.pdf
研修コーナー
l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
zsj2017 (Toyama) program.pdf
88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88
88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88
_170825_<52D5><7269><5B66><4F1A>_<6821><4E86><5F8C><4FEE><6B63>_<518A><5B50><4F53><FF08><5168><9801><FF09>.pdf
88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88
ｎｓｇ０４－２８／ｋｙ２０８６８４３５６１０００４３０７７
δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!
日本分子第5巻2号_15特別講演・シンポジウム.indd
25 JSMI Report JSMI Report 26 41 JSMI Report JSMI Report 42 JSMI Report 54 55 JSMI Report JSMI Report 56 57 JSMI Report JSMI Report 58 59 JSMI Report JSMI Report 60 61 JSMI Report β JSMI Report 62 63 JSMI
NL09
Information September, 2005 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.9 September, 2005 3 2005 4 Japanese Association for Molecular Target Therapy of Cancer News Letter
202
202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 DS =+α log (Spread )+ β DSRate +γlend +δ DEx DS t Spread t 1 DSRate t Lend t DEx DS DEx Spread DS
ax 2 + bx + c = n 8 (n ) a n x n + a n 1 x n a 1 x + a 0 = 0 ( a n, a n 1,, a 1, a 0 a n 0) n n ( ) ( ) ax 3 + bx 2 + cx + d = 0 4
20 20.0 ( ) 8 y = ax 2 + bx + c 443 ax 2 + bx + c = 0 20.1 20.1.1 n 8 (n ) a n x n + a n 1 x n 1 + + a 1 x + a 0 = 0 ( a n, a n 1,, a 1, a 0 a n 0) n n ( ) ( ) ax 3 + bx 2 + cx + d = 0 444 ( a, b, c, d
ｎｓｇ０２－１３／ｋｙ０４５０５９３０１６０００３３２１０
φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W
4 4 θ X θ P θ 4. 0, 405 P 0 X 405 X P 4. () 60 () 45 () 40 (4) 765 (5) 40 B 60 0 P = 90, = ( ) = X
4 4. 4.. 5 5 0 A P P P X X X X +45 45 0 45 60 70 X 60 X 0 P P 4 4 θ X θ P θ 4. 0, 405 P 0 X 405 X P 4. () 60 () 45 () 40 (4) 765 (5) 40 B 60 0 P 0 0 + 60 = 90, 0 + 60 = 750 0 + 60 ( ) = 0 90 750 0 90 0
1 12 *1 *2 (1991) (1992) (2002) (1991) (1992) (2002) 13 (1991) (1992) (2002) *1 (2003) *2 (1997) 1
2005 1 1991 1996 5 i 1 12 *1 *2 (1991) (1992) (2002) (1991) (1992) (2002) 13 (1991) (1992) (2002) *1 (2003) *2 (1997) 1 2 13 *3 *4 200 1 14 2 250m :64.3km 457mm :76.4km 200 1 548mm 16 9 12 589 13 8 50m
N cos s s cos ψ e e e e 3 3 e e 3 e 3 e
3 3 5 5 5 3 3 7 5 33 5 33 9 5 8 > e > f U f U u u > u ue u e u ue u ue u e u e u u e u u e u N cos s s cos ψ e e e e 3 3 e e 3 e 3 e 3 > A A > A E A f A A f A [ ] f A A e > > A e[ ] > f A E A < < f ; >
F = 0 F α, β F = t 2 + at + b (t α)(t β) = t 2 (α + β)t + αβ G : α + β = a, αβ = b F = 0 F (t) = 0 t α, β G t F = 0 α, β G. α β a b α β α β a b (α β)
19 7 12 1 t F := t 2 + at + b D := a 2 4b F = 0 a, b 1.1 F = 0 α, β α β a, b /stlasadisc.tex, cusp.tex, toileta.eps, toiletb.eps, fromatob.tex 1 F = 0 F α, β F = t 2 + at + b (t α)(t β) = t 2 (α + β)t
y = x x R = 0. 9, R = σ $ = y x w = x y x x w = x y α ε = + β + x x x y α ε = + β + γ x + x x x x' = / x y' = y/ x y' =
y x = α + β + ε =,, ε V( ε) = E( ε ) = σ α $ $ β w ( 0) σ = w σ σ y α x ε = + β + w w w w ε / w ( w y x α β ) = α$ $ W = yw βwxw $β = W ( W) ( W)( W) w x x w x x y y = = x W y W x y x y xw = y W = w w
日歯雑誌（Ｈ２８・８月号）別刷り／ポスターセッション とびら
α P. gingivalis P. gingivalis αsmatgf- VEGF-A α in vitro μ Porphyromonas gingivalis in vitro Porphyromonas gingivalis β β β JBiolChem. μ μ μ β Porphyromonas gingivalis in vitro μ α β α
n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m
![n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m](/thumbs/94/118912662.jpg "n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m")
1 1 1 + 1 4 + + 1 n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m a n < ε 1 1. ε = 10 1 N m, n N a m a n < ε = 10 1 N
内科９６巻３号★／ＮＡＩ３‐１（第２２回試験問題）
µ µ α µ µ µ µ µ µ β β α γ µ Enterococcus faecalis Escherichia coli Legionella pneumophila Pseudomonas aeruginosa Streptococcus viridans α β 正解表正解記号問題 No. 正解記号問題 No. e(4.5) 26 e 1 a(1.2) 27 a 2
O x y z O ( O ) O (O ) 3 x y z O O x v t = t = 0 ( 1 ) O t = 0 c t r = ct P (x, y, z) r 2 = x 2 + y 2 + z 2 (t, x, y, z) (ct) 2 x 2 y 2 z 2 = 0
9 O y O ( O ) O (O ) 3 y O O v t = t = 0 ( ) O t = 0 t r = t P (, y, ) r = + y + (t,, y, ) (t) y = 0 () ( )O O t (t ) y = 0 () (t) y = (t ) y = 0 (3) O O v O O v O O O y y O O v P(, y,, t) t (, y,, t )
朕醩佑宖醸æ−žã†®ã†�ã‡†ã†®æ··å’‹æŁ´æŁ°è¨‹çfl»ã…¢ã…⁄ã…«
1 / 34 Li-Yao,, Li-Yao The Life-Cycle Effects of House Price Changes (Li-Yao ),,,, ( ) 1 ω ( ) ω 1 γ Ct Ht t T βt U(C t, H t, N t) = N t N t t T βt N t 1 γ H t : t C t : t β : ω : γ : W. Li, R. Yao, The
1. z dr er r sinθ dϕ eϕ r dθ eθ dr θ dr dθ r x 0 ϕ r sinθ dϕ r sinθ dϕ y dr dr er r dθ eθ r sinθ dϕ eϕ 2. (r, θ, φ) 2 dr 1 h r dr 1 e r h θ dθ 1 e θ h
IB IIA 1 1 r, θ, φ 1 (r, θ, φ)., r, θ, φ 0 r
70 : 20 : A B (20 ) (30 ) 50 1
70 : 0 : A B (0 ) (30 ) 50 1 1 4 1.1................................................ 5 1. A............................................... 6 1.3 B............................................... 7 8.1 A...............................................
授業研究第1日目
1 1 1 0. (sextant) ( ) 2 1. IB I AB I AI E H H E B GHE CIHE ( ) 2 2 I H A (0 ) ( ) 3 2 2 θ = α + γ β + γ = θ + α β + γ = ( α + γ ) + α β = 2 α + γ γ C H CIG ( ) 4 2. John Hadley 1731 5 ( (octant)) Captain
10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1
4 16 1 10:0010 : 24 1F Annex 1! 2 15:0015 : 24 1F Annex 1!! 10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1 ! 2 10:0010 : 28 1F Annex 1 3 15:0015 : 28 1F Annex 1 4 10:3010 : 58 1F Annex 1 1 15:3015
( )
) ( ( ) 3 15m t / 1.9 3 m t / 0.64 3 m ( ) ( ) 3 15m 3 1.9m / t 0.64m 3 / t ) ( β1 β 2 β 3 y ( ) = αx1 X 2 X 3 ( ) ) ( ( ) 3 15m t / 1.9 3 m 3 90m t / 0.64 3 m ( ) : r : ) 30 ( 10 0.0164
NL10
Information September, 2006 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10 September, 2006 3 2006 4 Japanese Association for Molecular Target Therapy of Cancer News Letter
untitled
The 23rd Annual Meeting of the Japanese Association of Cardiac Rehabilitation! The 23rd Annual Meeting of the Japanese Association of Cardiac Rehabilitation The 23rd Annual Meeting of the Japanese Association
387 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )
386 B B () () ( ) ( ) ( ) 387 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) 388 ( ) ( ) ( ) 389 ( ) 2 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) 390 ( ) ( ) ( ) () () ( ) Hot flush 391 ( ) ( ) ( ) 392 ( ( )
概況
2 4 6 2 2 2 3 2 4 22 5 23 27 34 37 44 45 46 2 78.67 85.77 2.6. 7. 2 2, 65 85,464 93,8 65 85.5 93.2 8 56.2 77.9 2 8.87 88.8 3 () 65 3 6 2 2 2 2 2 22 3 2 2 2 2 2 2 2 2 28.58 28.74 29.9 8.8 8.84 2.63 65 28.3
日本医科大学医学会雑誌第8巻第1号
Xenopus laevis in situ μ μ Xenopus laevis Xenopus laevis Xenopus laevis UGT1A1 UGT1A1 IL28B KRAS UGT1A1 UGT1A128 UGT UGT1A1 UGT1A128 UGT1A1 286 UGT1A1 UGT1A1 28 6 UGT UGT UGT1A128 UGT IL28B UGT1A1
> > <., vs. > x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D > 0 x (2) D = 0 x (3
13 2 13.0 2 ( ) ( ) 2 13.1 ( ) ax 2 + bx + c > 0 ( a, b, c ) ( ) 275 > > 2 2 13.3 x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D >
CVMに基づくNi-Al合金の
CV N-A (-' by T.Koyama ennard-jones fcc α, β, γ, δ β α γ δ = or α, β. γ, δ α β γ ( αβγ w = = k k k ( αβγ w = ( αβγ ( αβγ w = w = ( αβγ w = ( αβγ w = ( αβγ w = ( αβγ w = ( αβγ w = ( βγδ w = = k k k ( αγδ
2003 12 11 1 http://www.sml.k.u-tokyo.ac.jp/members/nabe/lecture2003 http://www.sml.k.u-tokyo.ac.jp/members/nabe/lecture2002 nabe@sml.k.u-tokyo.ac.jp 2 1. 10/ 9 2. 10/16 3. 10/23 ( ) 4. 10/30 5. 11/ 6
_<74B0><5883><611F><67D3><30DD><30B1><30D7><30ED>_<5FF5><6821>2.pdf
33 The 33rd Annual Meeting of Japanese Society for Infection Prevention and Control The 33rd Annual Meeting of Japanese Society for Infection Prevention and Control The 33rd Annual Meeting of Japanese
9 5 ( α+ ) = (α + ) α (log ) = α d = α C d = log + C C 5. () d = 4 d = C = C = 3 + C 3 () d = d = C = C = 3 + C 3 =
5 5. 5.. A II f() f() F () f() F () = f() C (F () + C) = F () = f() F () + C f() F () G() f() G () = F () 39 G() = F () + C C f() F () f() F () + C C f() f() d f() f() C f() f() F () = f() f() f() d =
/ 3 1 / 3 / 3 1 /
8-18-29 3 291415 297 1-11-4 3/31/ 3/31/ 29 8 22 29 1 17 24 8-1 29 [1] PCB [2] HCB [3] [4] [5] DDT [6-1] p,p'-ddt [6-2] p,p'-dde pg/l ( ) nd 2,4 (46/47) 2.9 18 (47/47) 84 12 pg/g-dry ( ) nd 61, (61/62)
喘息について\(公健協会宛02-5作成\)
Q & A Q & A 1.? 20 2. 1) 2) 3) 4) 5) 6) 7) 1) 2) 3) 4) 5) 6) 7) 8) 9) 3. NHK ( ) 4 10 1 200mg ( ) ( 1 ) 4. ( ) ( ) 5. ( ) ( ) 6. β 2 ( ) 7. ( ) 1 8. 1. 2. 3. 4. 5. 6. 7. 8. 9. 2 5 7 1. 1 10 1) 2) 3) 30
original: 2011/11/5 revised: 2012/10/30, 2013/12/ : 2 V i V t2 V o V L V H V i V i V t1 V o V H V L V t1 V t2 1 Q 1 1 Q
original: 2011/11/5 revised: 2012/10/30, 2013/12/2 1 1 1: 2 V i V t2 V o V L V H V i V i V t1 V o V H V L V t1 V t2 1 Q 1 1 Q 2 2 1 2 1 c 2013 2 2: V i Q 1 I C1 V C1 V B2 I E V E V E Q 1 Q 1 Q 2 Q 2 Q
1. 1 A : l l : (1) l m (m 3) (2) m (3) n (n 3) (4) A α, β γ α β + γ = 2 m l lm n nα nα = lm. α = lm n. m lm 2β 2β = lm β = lm 2. γ l 2. 3
1. 1 A : l l : (1) l m (m 3) (2) m (3) n (n 3) (4) A 2 1 2 1 2 3 α, β γ α β + γ = 2 m l lm n nα nα = lm. α = lm n. m lm 2β 2β = lm β = lm 2. γ l 2. 3 4 P, Q R n = {(x 1, x 2,, x n ) ; x 1, x 2,, x n R}
「スウェーデン企業におけるワーク・ライフ・バランス調査 」報告書
1 2004 12 2005 4 5 100 25 3 1 76 2 Demoskop 2 2004 11 24 30 7 2 10 1 2005 1 31 2 4 5 2 3-1-1 3-1-1 Micromediabanken 2005 1 507 1000 55.0 2 77 50 50 /CEO 36.3 37.4 18.1 3-2-1 43.0 34.4 / 17.6 3-2-2 78 79.4
NL11
information September, 2007 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11 September, 2007 3 2007 4 Japanese Association for Molecular Target Therapy of Cancer News Letter
untitled
( ) δ x V A A V V + x x δ A + x x δ x A V Q AV A+ δx V + δx V A A V AV + A δx+ V δx+ δx V A A δx+ V δx V A A + V ( ) ( AV ) AV Constant Q 1 Text 7.1 ( ) P1 7 7.P8 5 D v g z x + x 1 v ( v+ x ) g + x z z
3/4/8:9 { } { } β β β α β α β β
α β : α β β α β α, [ ] [ ] V, [ ] α α β [ ] β 3/4/8:9 3/4/8:9 { } { } β β β α β α β β [] β [] β β β β α ( ( ( ( ( ( [ ] [ ] [ β ] [ α β β ] [ α ( β β ] [ α] [ ( β β ] [] α [ β β ] ( / α α [ β β ] [ ] 3
免疫Ⅱ
100 100 100 1990 127 DNA DNA DNA DNA hybridization DNA RNA DNA DNA 128 12 µδγαε 129 300 1,200 500 50012 4 24,000 1,20024,000 2.910 7 10 8 rejection major histocompatibility complex MHC MHC MHC 130 MHC
さくらの個別指導 ( さくら教育研究所 ) 1 φ = φ 1 : φ [ ] a [ ] 1 a : b a b b(a + b) b a 2 a 2 = b(a + b). b 2 ( a b ) 2 = a b a/b X 2 X 1 = 0 a/b > 0 2 a
![さくらの個別指導 ( さくら教育研究所 ) 1 φ = φ 1 : φ [ ] a [ ] 1 a : b a b b(a + b) b a 2 a 2 = b(a + b). b 2 ( a b ) 2 = a b a/b X 2 X 1 = 0 a/b > 0 2 a](/thumbs/97/131721994.jpg "さくらの個別指導 ( さくら教育研究所 ) 1 φ = φ 1 : φ [ ] a [ ] 1 a : b a b b(a + b) b a 2 a 2 = b(a + b). b 2 ( a b ) 2 = a b a/b X 2 X 1 = 0 a/b > 0 2 a")
φ + 5 2 φ : φ [ ] a [ ] a : b a b b(a + b) b a 2 a 2 b(a + b). b 2 ( a b ) 2 a b + a/b X 2 X 0 a/b > 0 2 a b + 5 2 φ φ : 2 5 5 [ ] [ ] x x x : x : x x : x x : x x 2 x 2 x 0 x ± 5 2 x x φ : φ 2 : φ ( )
r 1 m A r/m i) t ii) m i) t B(t; m) ( B(t; m) = A 1 + r ) mt m ii) B(t; m) ( B(t; m) = A 1 + r ) mt m { ( = A 1 + r ) m } rt r m n = m r m n B
1 1.1 1 r 1 m A r/m i) t ii) m i) t Bt; m) Bt; m) = A 1 + r ) mt m ii) Bt; m) Bt; m) = A 1 + r ) mt m { = A 1 + r ) m } rt r m n = m r m n Bt; m) Aert e lim 1 + 1 n 1.1) n!1 n) e a 1, a 2, a 3,... {a n
.\ /......
教育 研究 社会貢献活動報告 香 川 医 科 大 学 平成１ ３年度 香川医科大学自己点検評価委員会 γ α β β β α β β γ γ α β αβ µ Anopheles Bolbosoma Leishmania Pneumocystis carinii P. carinii Bolbosoma Leishmania Anopheles Plasmodium
BD = a, EA = b, BH = a, BF = b 3 EF B, EOA, BOD EF B EOA BF : AO = BE : AE, b : = BE : b, AF = BF = b BE = bb. () EF = b AF = b b. (2) EF B BOD EF : B
2000 8 3.4 p q θ = 80 B E a H F b θ/2 O θ/2 D A B E BD = a, EA = b, BH = a, BF = b 3 EF B, EOA, BOD EF B EOA BF : AO = BE : AE, b : = BE : b, AF = BF = b BE = bb. () EF = b AF = b b. (2) EF B BOD EF :
コロナ社 Q&A Question and Answer Q&A
Q&A Question and Answer Q&A ii Q&A 1999 Q&A Q&A Q&A 8 Q&A 2007 2 1. 1.1... 1 1.1.1... 1 1.1.2... 6 1.2... 7 1.2.1... 7 1.2.2... 11 1.3... 18 1.3.1... 18 1.3.2... 20... 25 2. 2.1... 26 2.2... 33... 38 3.
kogi dvi
10 4 23 ( ) email: tanikawa.ky@nao.ac.jp I. ( ) II. : III. ( ) 1 I. : ( ) :, : :, :? : = : =, ( ). 2 1.... ( ).. (,,,, ),,, ( ) ( ). ( )... ( ).?. 3 1: ( T)... 19 F.R. Stephenson 1990 ΔT 4 II. : (i) (ii))
Chapter9 9 LDPC sum-product LDPC 9.1 ( ) 9.2 c 1, c 2, {0, 1, } SUM, PROD : {0, 1, } {0, 1, } SUM(c 1, c 2,, c n ) := { c1 + + c n (c n0 (1 n
9 LDPC sum-product 9.1 9.2 LDPC 9.1 ( ) 9.2 c 1, c 2, {0, 1, } SUM, PROD : {0, 1, } {0, 1, } SUM(c 1, c 2,, c n ) := { c1 + + c n (c n0 (1 n 0 n)) ( ) 0 (N(0 c) > N(1 c)) PROD(c 1, c 2,, c n ) := 1 (N(0
untitled
( 9:: 3:6: (k 3 45 k F m tan 45 k 45 k F m tan S S F m tan( 6.8k tan k F m ( + k tan 373 S S + Σ Σ 3 + Σ os( sin( + Σ sin( os( + sin( os( p z ( γ z + K pzdz γ + K γ K + γ + 9 ( 9 (+ sin( sin { 9 ( } 4
,398 4% 017,
6 3 JEL Classification: D4; K39; L86,,., JSPS 34304, 47301.. 1 01301 79 1 7,398 4% 017,390 01 013 1 1 01 011 514 8 1 Novos and Waldman (1984) Johnson (1985) Chen and Png (003) Arai (011) 3 1 4 3 4 5 0
ALM
ALM 4 60025480 1 1.1 1.1.1 1.1.2 1.2 ALM 2. 2.11 2.1.1 2.1.2 2.2 2.3 3. 3.1 3.1.1 3.1.2 3.1.3 3.1.4 3.2 3.2.1 3.2.2 4. 4.1 4.1.1 4.1.2 4.1.3 4.2 4.2.1 4.2.2 4.2.3 5. 5.1 5.1.1 5.1.2 5.2 2 6. 6.1 6.2 6.1.1
II Karel Švadlenka * [1] 1.1* 5 23 m d2 x dt 2 = cdx kx + mg dt. c, g, k, m 1.2* u = au + bv v = cu + dv v u a, b, c, d R
![II Karel Švadlenka * [1] 1.1* 5 23 m d2 x dt 2 = cdx kx + mg dt. c, g, k, m 1.2* u = au + bv v = cu + dv v u a, b, c, d R](/thumbs/95/125540821.jpg "II Karel Švadlenka * [1] 1.1* 5 23 m d2 x dt 2 = cdx kx + mg dt. c, g, k, m 1.2* u = au + bv v = cu + dv v u a, b, c, d R")
II Karel Švadlenka 2018 5 26 * [1] 1.1* 5 23 m d2 x dt 2 = cdx kx + mg dt. c, g, k, m 1.2* 5 23 1 u = au + bv v = cu + dv v u a, b, c, d R 1.3 14 14 60% 1.4 5 23 a, b R a 2 4b < 0 λ 2 + aλ + b = 0 λ =
Lecture 12. Properties of Expanders
Lecture 12. Properties of Expanders M2 Mitsuru Kusumoto Kyoto University 2013/10/29 Preliminalies G = (V, E) L G : A G : 0 = λ 1 λ 2 λ n : L G ψ 1,..., ψ n : L G µ 1 µ 2 µ n : A G ϕ 1,..., ϕ n : A G (Lecture
Evolutes and involutes of fronts Masatomo Takahashi Muroran Institute of Technology
Evolutes and involutes of fronts Masatomo Takahashi Muroran Institute of Technology evolute involute, evolvent involute : involvo evolvent : evolvo 6 4 6 4 4 6 4 6 H 3 γ : I R C γ(t) 0, t(t) := γ(t) γ(t),
2.7.6 MJR a MRI CT b 2 Beecham r-afs mg/ mg/ Gn-RH 742
MJR-35 34 1 1 a MRICT b 2Beecham r-afs 3 4 20 4 mg/ 20 40 5 6 2 1 2 3 44 mg/ 5 6 7 8 4 Gn-RH 742 9 10 11 12 1 20 60 1 1MJR-351 mg/ 0.25 2 Lot. No. 2MJR-352 mg/ 1 1 Lot. No. 3MJR-354 mg/ 1 2 Lot. No. 2
‚åŁÎ“·„´Šš‡ðŠp‡¢‡½‹âfi`fiI…A…‰…S…−…Y…•‡ÌMarkovŸA“½fiI›ð’Í
Markov 2009 10 2 Markov 2009 10 2 1 / 25 1 (GA) 2 GA 3 4 Markov 2009 10 2 2 / 25 (GA) (GA) L ( 1) I := {0, 1} L f : I (0, ) M( 2) S := I M GA (GA) f (i) i I Markov 2009 10 2 3 / 25 (GA) ρ(i, j), i, j I
KEIRIN
KEIRIN KEIRIN PCOSS CIO PC PC OSS OSS 2003 CIO 2003 IT IT 2006 2006 IT IT IT IT 2008 2008 IT IT 2001 2001 5IT IT 5IT IT IT IT (NGN) Web2.0 (NGN) Web2.0 2005 IT CIO 2005 2005 IT CIO 2006 CIOIT IT SE 2006
研修コーナー
l l l l l l l Department of Obstetrics and Gynecology, Fukui Medical University, Fukui l l l l l l µ l β β l α l µ µ l l l l Department of Obstetrics and Gynecology, Gifu University School of Medicine,
支持力計算法.PDF
. (a) P P P P P P () P P P P (0) P P Hotω H P P δ ω H δ P P (a) ( ) () H P P n0(k P 4.7) (a)0 0 H n(k P 4.76) P P n0(k P 5.08) n0(k P.4) () 0 0 (0 ) n(k P 7.56) H P P n0(k P.7) n(k P.7) H P P n(k P 5.4)
指数関数的進化企業に及ぼす弱い連携の影響 日産自動車, 富士フイルム, 川崎重工業のイノベーションの源泉 1 115 12 13 14 15 16 2 21 22 23 24 25 3 31 32 321 322 323 332 4 41 42 43 5-17 - 18 1 115 4 5 9 1 5 5 2 152045 2 3 12015 22015 1000111000 100111200 112
R R 16 ( 3 )
(017 ) 9 4 7 ( ) ( 3 ) ( 010 ) 1 (P3) 1 11 (P4) 1 1 (P4) 1 (P15) 1 (P16) (P0) 3 (P18) 3 4 (P3) 4 3 4 31 1 5 3 5 4 6 5 9 51 9 5 9 6 9 61 9 6 α β 9 63 û 11 64 R 1 65 13 66 14 7 14 71 15 7 R R 16 http://wwwecoosaka-uacjp/~tazak/class/017